{"denoms":[{"counts":[{"groupId":"BG000","value":"406"},{"groupId":"BG001","value":"399"},{"groupId":"BG002","value":"805"}],"units":"Participants"}],"groups":[{"description":"Intensity-modulated radiotherapy (IMRT) with concurrent cisplatin\n\nCisplatin: 100 mg/m2 IV on days 1 and 22 of IMRT\n\nIMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.","id":"BG000","title":"IMRT + Cisplatin"},{"description":"Intensity-modulated radiotherapy (IMRT) with concurrent cetuximab\n\nCetuximab: 400 mg/m2 IV 5-7 days before IMRT then 250 mg/m2 IV weekly for 7 weeks\n\nIMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.","id":"BG001","title":"IMRT + Cetuximab"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"52","upperLimit":"63","value":"58"},{"groupId":"BG001","lowerLimit":"52","upperLimit":"63","value":"58"},{"groupId":"BG002","lowerLimit":"52","upperLimit":"63","value":"58"}]}]}],"dispersionType":"INTER_QUARTILE_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"344"},{"groupId":"BG001","value":"345"},{"groupId":"BG002","value":"689"}]}],"title":"<= 65"},{"categories":[{"measurements":[{"groupId":"BG000","value":"62"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"116"}]}],"title":"> 65"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"77"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"373"},{"groupId":"BG001","value":"355"},{"groupId":"BG002","value":"728"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"26"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"383"},{"groupId":"BG001","value":"369"},{"groupId":"BG002","value":"752"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"27"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"380"},{"groupId":"BG001","value":"367"},{"groupId":"BG002","value":"747"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"36"}]}],"title":"Black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"10"}]}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"12"}]}],"title":"Unknown"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"295"},{"groupId":"BG001","value":"300"},{"groupId":"BG002","value":"595"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"111"},{"groupId":"BG001","value":"99"},{"groupId":"BG002","value":"210"}]}],"title":"1"}],"description":"Measure Description: 0 - Asymptomatic; 1 - Symptomatic but completely ambulatory; 2 - Symptomatic, \\<50% in bed during the day; 3 - Symptomatic, \\>50% in bed, but not bedbound; 4 - Bedbound; 5 - Death","paramType":"COUNT_OF_PARTICIPANTS","title":"Zubrod performance status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"194"},{"groupId":"BG001","value":"181"},{"groupId":"BG002","value":"375"}]}],"title":"0 pack-years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"59"},{"groupId":"BG001","value":"68"},{"groupId":"BG002","value":"127"}]}],"title":">0 to <= 10 pack-years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"153"},{"groupId":"BG001","value":"150"},{"groupId":"BG002","value":"303"}]}],"title":">10 pack-years"}],"description":"Smoking history as measured in pack-years. It is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.","paramType":"COUNT_OF_PARTICIPANTS","title":"Smoking history","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"0","upperLimit":"22","value":"2"},{"groupId":"BG001","lowerLimit":"0","upperLimit":"24","value":"3"},{"groupId":"BG002","lowerLimit":"0","upperLimit":"23","value":"2"}]}]}],"description":"Measure Description: Smoking history as measured in pack-years. It is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.","dispersionType":"INTER_QUARTILE_RANGE","paramType":"MEDIAN","title":"Smoking history","unitOfMeasure":"pack-years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"202"},{"groupId":"BG001","value":"199"},{"groupId":"BG002","value":"401"}]}],"title":"Tonsillar fossa, tonsil"},{"categories":[{"measurements":[{"groupId":"BG000","value":"174"},{"groupId":"BG001","value":"179"},{"groupId":"BG002","value":"353"}]}],"title":"Base of tongue"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"31"}]}],"title":"Oropharynx, not otherwise specified"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"13"}]}],"title":"Pharyngeal oropharynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"4"}]}],"title":"Soft palate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]}],"title":"Vallecula"}],"description":"Primary location of tumor","paramType":"COUNT_OF_PARTICIPANTS","title":"Primary site","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"89"},{"groupId":"BG001","value":"86"},{"groupId":"BG002","value":"175"}]}],"title":"T1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"162"},{"groupId":"BG001","value":"163"},{"groupId":"BG002","value":"325"}]}],"title":"T2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"108"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"208"}]}],"title":"T3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"47"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"97"}]}],"title":"T4"}],"description":"Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues.","paramType":"COUNT_OF_PARTICIPANTS","title":"Tumor stage","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"34"}]}],"title":"N0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"45"}]}],"title":"N1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"59"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"115"}]}],"title":"N2a"},{"categories":[{"measurements":[{"groupId":"BG000","value":"209"},{"groupId":"BG001","value":"208"},{"groupId":"BG002","value":"417"}]}],"title":"N2b"},{"categories":[{"measurements":[{"groupId":"BG000","value":"82"},{"groupId":"BG001","value":"83"},{"groupId":"BG002","value":"165"}]}],"title":"N2c"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"29"}]}],"title":"N3"}],"description":"Regional lymph nodes staging per American Joint Committee on Cancer (AJCC) 7th ed. refers to the number and/or extent of spread of lymph nodes that contain cancer. The higher the number after the N, the greater the involvement of regional lymph nodes.","paramType":"COUNT_OF_PARTICIPANTS","title":"Node category","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"60"}],"title":"III"},{"measurements":[{"groupId":"BG000","value":"377"},{"groupId":"BG001","value":"368"},{"groupId":"BG002","value":"745"}],"title":"IV"}]}],"description":"Overall cancer stage per American Joint Committee on Cancer (AJCC) 7th ed. combines tumor (T), regional lymph node (N), and distant metastasis (M) staging to determine an overall stage of 0, I, II, III, or IV, ranging from least to most advanced, respectively. Stage III: T3/N0/M0 or T1-3/N1/M0; Stage IV: T4/any N/M0 or any T/N2-3/M0.","paramType":"COUNT_OF_PARTICIPANTS","title":"Overall stage","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"289"},{"groupId":"BG001","value":"284"},{"groupId":"BG002","value":"573"}],"title":"Low risk"},{"measurements":[{"groupId":"BG000","value":"117"},{"groupId":"BG001","value":"115"},{"groupId":"BG002","value":"232"}],"title":"Intermediate risk"}]}],"description":"Risk group as defined by recursive partitioning analysis of study RTOG-0129 (NCT00047008). Low-risk consists of patients with p16-positive tumors and 10 or fewer pack-years or p16-positive, \\>10 pack-years, and N0-2a disease. Intermediate-risk consists of p16-positive, \\>10 pack-years, and N2b-3 disease or p16-negative, 10 or fewer pack-years, and T2-3 disease. High-risk consists of p16-negative, 10 or fewer pack-years, and T4 disease or p16-negative and \\>10 pack-years.","paramType":"COUNT_OF_PARTICIPANTS","title":"Risk group per study RTOG-0129","unitOfMeasure":"Participants"}],"populationDescription":"Eligible participants"}